⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

Official Title: A Phase II Study of IL-18 in Melanoma Patients

Study ID: NCT00107718

Conditions

Melanoma

Interventions

SB-485232

Study Description

Brief Summary: This Phase II study is designed to evaluate the anti-tumor activity of three dose groups of SB-485232 (0.01, 0.1, and 1.0 mg/kg/day) administered intravenously as a single agent in subjects with previously untreated metastatic melanoma.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, San Francisco, California, United States

GSK Investigational Site, Santa Monica, California, United States

GSK Investigational Site, New Haven, Connecticut, United States

GSK Investigational Site, Jacksonville, Florida, United States

GSK Investigational Site, Miami Beach, Florida, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, Indianapolis, Indiana, United States

GSK Investigational Site, Lutherville-Timonium, Maryland, United States

GSK Investigational Site, New York, New York, United States

GSK Investigational Site, Toledo, Ohio, United States

GSK Investigational Site, Pittsburgh, Pennsylvania, United States

GSK Investigational Site, Waratah, New South Wales, Australia

GSK Investigational Site, Westmead, New South Wales, Australia

GSK Investigational Site, Douglas, Queensland, Australia

GSK Investigational Site, South Brisbane, Queensland, Australia

GSK Investigational Site, Woolloongabba, Queensland, Australia

GSK Investigational Site, Hobart, Tasmania, Australia

GSK Investigational Site, East Melbourne, Victoria, Australia

GSK Investigational Site, Nedlands, Western Australia, Australia

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: